FDA Approves Rasonque for Pancreatic Cancer Treatment

The FDA has approved Rasonque for the treatment of pancreatic adenocarcinoma, a cancer that accounts for a disproportionately large share of cancer deaths in the U.S. This approval represents a regulatory milestone for advanced cancer treatment technology.